EUVIMEDEUVIMED entdecken
Open Access

Optimizing Hepatitis C Virus Screening to Maximize Health Benefit Among Men Who Have Sex With Men in the United States: A Cost-Effectiveness Analysis

Natasha K Martin, Antoine Chaillon iD, Peter Vickerman, Louis MacGregor iD, Chidozie Williams Chukwu, Adriane Wynn, Daniel S Fierer iD

Clinical Infectious Diseases · 28.10.2026 · 83 (4) · 554-561

DOI: 10.1093/cid/ciag416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 15.07.2026. Verfasst von Natasha K Martin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Global Public Health, UC San Diego, California, San Diego, California, USA. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Homosexuality, Male, Hepatitis C, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Center for AIDS Research, Merck.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current US guidelines recommend annual hepatitis C virus (HCV) screening among men who have sex with men (MSM) with human immunodeficiency virus (HIV) and MSM on pre-exposure prophylaxis against HIV (PrEP), but these recommendations were based largely on expert opinion using interferon-era assumptions.

Methods

We calibrated a dynamic economic model of HCV transmission among MSM to US data to determine the cost effectiveness of HCV testing among MSM with HIV and/or using PrEP and among MSM not using PrEP, compared to status quo HCV testing. Program costs and quality-adjusted life years (QALYs) were calculated to determine the mean incremental cost-effectiveness ratio (ICER) of each testing combination compared to its next least costly permutation. We defined the optimal strategy as that having the highest health benefits but with an ICER below a willingness-to-pay threshold of $100 000/QALY gained.

Results

Six testing strategies dominated the other combinations. Implementing recommended annual screening among MSM with HIV was cost-saving compared to current testing rates. However, the optimal strategy was testing MSM with HIV every 6 months, MSM using PrEP every 12 months, and MSM not using PrEP when tested for HIV (ICER $67 092/QALY gained). The optimal strategy did not change under sensitivity analyses.

Conclusions

The optimal frequency of HCV testing to achieve maximum health benefit in a cost-effective manner for MSM in the United States is higher in 2 subgroups, MSM with HIV, and MSM not using PrEP, than current US guidelines recommend. HCV testing is currently performed less frequently than optimal. Expanding testing is needed to improve HCV outcomes among MSM in the United States.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Benefit AnalysisHomosexuality, MaleHepatitis CMass ScreeningHumansMaleCost-Effectiveness AnalysisUnited StatesHIV InfectionsQuality-Adjusted Life YearsHepacivirusPre-Exposure ProphylaxisAdult

Stichwörter der Autor:innen

dynamic mathematical modelingsexual transmissiontesting

Autor:innen und Institutionen

  • Division of Infectious Diseases and Global Public Health, UC San Diego, California, San Diego, California, USA.
  • Population Health Sciences, University of Bristol, Bristol, United Kingdom.
  • Data Heart, Nottingham, United Kingdom.
  • Department of Mathematical Sciences, Georgia Southern University, Statesboro, Georgia, USA.
  • Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Antoine Chaillon, Louis MacGregor, Daniel S Fierer

Förderung

  • NIAID NIH HHS
  • Center for AIDS Research
  • Merck
  • NIH

Zitieren

APA

Martin, N. K., Chaillon, A., Vickerman, P., MacGregor, L., Chukwu, C. W., Wynn, A., & Fierer, D. S. (2026). Optimizing Hepatitis C Virus Screening to Maximize Health Benefit Among Men Who Have Sex With Men in the United States: A Cost-Effectiveness Analysis. Clinical Infectious Diseases, 83(4), 554-561. https://doi.org/10.1093/cid/ciag416

Vancouver

Martin NK, Chaillon A, Vickerman P, MacGregor L, Chukwu CW, Wynn A, et al. Optimizing Hepatitis C Virus Screening to Maximize Health Benefit Among Men Who Have Sex With Men in the United States: A Cost-Effectiveness Analysis. Clinical Infectious Diseases. 2026;83(4):554-561. doi:10.1093/cid/ciag416

BibTeX
@article{Martin2026,
  author = {Martin, Natasha K and Chaillon, Antoine and Vickerman, Peter and MacGregor, Louis and Chukwu, Chidozie Williams and Wynn, Adriane and Fierer, Daniel S},
  title = {Optimizing Hepatitis C Virus Screening to Maximize Health Benefit Among Men Who Have Sex With Men in the United States: A Cost-Effectiveness Analysis},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {83},
  number = {4},
  pages = {554--561},
  doi = {10.1093/cid/ciag416}
}
Kostenlos starten →